Literature DB >> 1357271

Antiplatelet therapy in thrombotic thrombocytopenic purpura.

P Revell, N G Slater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1357271     DOI： 10.1016/0140-6736(92)92727-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis.

Authors:  Zohra R Malik; Amir Shahbaz; Kashif Aziz; Zareen Razaq; Muhammad Umair; Issac Sachmechi
Journal:  Cureus       Date:  2018-08-20

2.  Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Sara K Vesely; Spero R Cataland; Paul Coppo; Brian Geldziler; Alfonso Iorio; Masanori Matsumoto; Reem A Mustafa; Menaka Pai; Gail Rock; Lene Russell; Rawan Tarawneh; Julie Valdes; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-09-11       Impact factor: 5.824

Review 3.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

4.  Thrombotic Thrombocytopenic Purpura Associated with Myelodysplastic Syndrome.

Authors:  Zohra R Malik; Nassim Mokraoui; Zareen Razaq; Gabriela L Severiano; Arnaud Yanogo
Journal:  Cureus       Date:  2020-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.